• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Jun;18(6):e13345.
doi: 10.1111/irv.13345. Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023

Kohei Shimizu[SUP] 1 [/SUP], Chiharu Kawakami[SUP] 1 2 3 [/SUP], Yoko Matsuzaki[SUP] 4 [/SUP], Seiichiro Fujisaki[SUP] 5 [/SUP], Shiho Nagata[SUP] 5 [/SUP], Hiroko Morita[SUP] 5 [/SUP], Kayo Watanabe[SUP] 5 [/SUP], Hideka Miura[SUP] 5 [/SUP], Tomoko Momoki[SUP] 1 [/SUP], Miwako Saikusa[SUP] 1 [/SUP], Hiroki Ozawa[SUP] 1 [/SUP], Makoto Kumazaki[SUP] 1 [/SUP], Shuzo Usuku[SUP] 1 [/SUP], Nobuko Tanaka[SUP] 1 [/SUP], Ryuichi Senda[SUP] 1 [/SUP], Ichiro Okubo[SUP] 1 [/SUP], Shinji Watanabe[SUP] 5 [/SUP], Hideki Hasegawa[SUP] 5 [/SUP], Yoshihiro Kawaoka[SUP] 2 3 6 7 [/SUP], Emi Takashita[SUP] 5 [/SUP]



Affiliations
Free PMC article Abstract

Background: Influenza viruses can cause zoonotic infections that pose public health risks. Surveillance of influenza A and B viruses is conducted globally; however, information on influenza C and D viruses is limited. Longitudinal monitoring of influenza C virus in humans has been conducted in several countries, but there has been no long-term monitoring of influenza D virus in humans. The public health risks associated with the influenza D virus therefore remain unknown.
Methods: We established a duplex real-time RT-PCR to detect influenza C and D viruses and analyzed respiratory specimens collected from 2144 patients in Japan with respiratory diseases between January 2018 and March 2023. We isolated viruses and conducted hemagglutination inhibition tests to examine antigenicity and focus reduction assays to determine susceptibility to the cap-dependent endonuclease inhibitor baloxavir marboxil.
Results: We detected three influenza C viruses belonging to the C/Kanagawa- or C/Sao Paulo-lineages, which recently circulated globally. None of the specimens was positive for the influenza D virus. The C/Yokohama/1/2022 strain, isolated from the specimen with the highest viral RNA load and belonging to the C/Kanagawa-lineage, showed similar antigenicity to the reference C/Kanagawa-lineage strain and was susceptible to baloxavir.
Conclusions: Our duplex real-time RT-PCR is useful for the simultaneous detection of influenza C and D viruses from the same specimen. Adding the influenza D virus to the monitoring of the influenza C virus would help in assessing the public health risks posed by this virus.

Keywords: influenza C; influenza D; surveillance; zoonotic infection.

 
Back
Top Bottom